Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

NF-κB functions as a tumour promoter in inflammation-associated cancer

Eli Pikarsky, Rinnat M. Porat, Ilan Stein et al. · Nature · 2004 · 2.4K citations

Life Sciences, Cancer Biology, Oncology +16

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text

Medicine, Cancer Biology, Oncology +16

A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

Winnie Yeo, Tony Mok, Benny Zee et al. · JNCI Journal of the National Cancer Institute · 2005 · 589 citations · Full text

Medicine, Oncology, Pharmacology +14

Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity

Xiaohang Long, Chi Chun Wong, Li Tong et al. · Nature Microbiology · 2019 · 547 citations

Life Sciences, Microbiology, Oncology +14